Mode
Text Size
Log in / Sign up

Cardiac Amyloidosis

Subtypes of Cardiac Amyloidosis

Cerebral Amyloid Angiopathy 2

7 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Cardiac Amyloidosis

2 trials tracked for Cardiac Amyloidosis: 1 in phase 3 or 4 and 1 with published results. The most-cited published study has 310 citations.

2Trials tracked
1Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 1 Other / NA 1
  1. Phase 4 Imaging Cardiac Amyloidosis: A Pilot Study Using F-18 Florbetapir Positron Emission Tomography Completed · 310 cited
  2. N/A Cardiac Amyloidosis Discovery Trial Completed

Showing the 2 most-cited and recently-updated of 2 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Questions about Cardiac Amyloidosis

Which imaging tests are best for distinguishing cardiac amyloidosis from other heart issues?

Cardiac MRI with contrast and bone scintigraphy are the best tests for distinguishing cardiac amyloidosis from other heart issues, with echocardiography as a useful first screening tool.

Full answer →
Can an apical sparing ratio help detect cardiac amyloidosis in my heart?

Yes, the apical sparing ratio (ASR) can help detect cardiac amyloidosis, but it is not perfect—it has moderate accuracy and should be used alongside other tests.

Full answer →